Fig. 5.
- ID
- ZDB-FIG-220104-57
- Publication
- Habjan et al., 2021 - Anti-tuberculosis Compound Screen using a Zebrafish Infection Model identifies an Aspartyl-tRNA Synthetase Inhibitor
- Other Figures
- All Figure Page
- Back to All Figure Page
TBA161-C has potent activity in the zebrafish infection model compared to other AspS inhibitors. (A) The chemical structures of the test compounds, TBA161-C, C1 and GSK93A. (B) Zebrafish embryos were yolk infected with M. marinum-tdTomato and treated with compounds at the indicated concentrations. Each data point represents the integrated red fluorescence intensity of a single zebrafish embryo, and the signal of each group is expressed as meanąs.e.m. Statistical significance was determined by one-way ANOVA, following Dunnett's multiple comparison test by comparing the signal from the DMSO-treated control sample with each treatment group (***P?0.001, ****P?0.0001). |